BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34515990)

  • 1. Long non-coding RNA CCAT2 drives the growth of laryngeal squamous cell carcinoma via regulating YAP activity.
    Zang Y; Li J; Wan B; Tai Y; Liu H; Li Q; Ji Y
    Hum Cell; 2021 Nov; 34(6):1878-1887. PubMed ID: 34515990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Long Noncoding RNA CCAT2 Suppresses Malignant Phenotype in Human Laryngeal Squamous Cell Carcinoma.
    Li M; An J; Ren H; Gui J; Wang H; Wu S; Wu R; Xiao H; Wang L
    Bull Exp Biol Med; 2023 Sep; 175(5):673-680. PubMed ID: 37874495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.
    Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B
    Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis.
    Wang X; Yu B; Jin Q; Zhang J; Yan B; Yang L; Li Y; Li Q; Wang P; Sun C; Liu M; Tian L; Sun Y
    J Cell Mol Med; 2020 Jun; 24(12):6781-6795. PubMed ID: 32363688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis.
    Xu Z; Xi K
    Biomed Pharmacother; 2019 Oct; 118():109222. PubMed ID: 31351424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MNX1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
    Ma B; Ren G; Xu J; Yin C; Shi Y
    Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
    Yuan H; Jiang H; Wang Y; Dong Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00319 promotes cancer stem cell-like properties in laryngeal squamous cell carcinoma via E2F1-mediated upregulation of HMGB3.
    Yuan L; Tian X; Zhang Y; Huang X; Li Q; Li W; Li S
    Exp Mol Med; 2021 Aug; 53(8):1218-1228. PubMed ID: 34408262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
    Cui X; Yu H; Yu T; Xiao D; Wang X
    Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway.
    Wang P; Wu T; Zhou H; Jin Q; He G; Yu H; Xuan L; Wang X; Tian L; Sun Y; Liu M; Qu L
    J Exp Clin Cancer Res; 2016 Jan; 35():22. PubMed ID: 26822763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA XIST promotes the progression of laryngeal squamous cell carcinoma by sponging miR‑144 to regulate IRS1 expression.
    Cui CL; Li YN; Cui XY; Wu X
    Oncol Rep; 2020 Feb; 43(2):525-535. PubMed ID: 31894287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
    Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
    Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
    Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
    Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
    Dang Y; Zhang L; Wang X
    J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.